ROTHBLATT MARTINE A bought UTHR
December 19, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 2,000 shares of United Therapeutics Corporation at $120.26 per share, a transaction worth $240.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$120.26
Total value
$240.5K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 19, 2025
Filing dateDecember 19, 2025
Shares owned after2,130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. The transactions reported on this Form 4 are the final trades under this plan.